Keefe Bruyette re-initiated coverage of Globe Life (GL) with an Outperform rating and $168 price target The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Globe Life initiated with a Buy at Texas Capital
- Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
- Globe Life price target raised to $171 from $170 at Wells Fargo
- Globe Life price target raised to $157 from $155 at Evercore ISI
- Globe Life Earnings Call Highlights Resilient Growth